Showing results (141-150 of 181) with videos related to

Sort By:
Pageof 19
Diabetologia|June 1, 2006
Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75)I M Stratton, C A Cull, A I Adler, et al.
Diabetes, Obesity & Metabolism|September 19, 2012
Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 studyM Nauck, A Frid, K Hermansen, et al.
Diabetologia|July 1, 1985
Continuous infusion of glucose with model assessment: measurement of insulin resistance and beta-cell function in manJ P Hosker, D R Matthews, A S Rudenski, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 13, 1999
Glycaemic control and familial factors determine hyperlipidaemia in early childhood diabetes. Oxford Regional Prospective Study of Childhood DiabetesA Abraha, C Schultz, T Konopelska-Bahu, et al.
The Journal of Endocrinology|February 1, 1993
Short-term endocrine consequences of total body irradiation and bone marrow transplantation in children treated for leukemiaM Ryalls, H A Spoudeas, P C Hindmarsh, et al.
BMJ (Clinical Research Ed.)|April 29, 1998
Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)R C Turner, H Millns, H A Neil, et al.
Diabetologia|August 1, 1995
UK prospective diabetes study (UKPDS) 14: association of angiotensin-converting enzyme insertion/deletion polymorphism with myocardial infarction in NIDDMB D Keavney, C R Dudley, I M Stratton, et al.
Journal of Microscopy|January 9, 2010
Time-lapse FRET microscopy using fluorescence anisotropyD R Matthews, L M Carlin, E Ofo, et al.
Clinical Endocrinology|April 1, 1989
The half-life of exogenous growth hormone after suppression of endogenous growth hormone secretion with somatostatinP C Hindmarsh, D R Matthews, C E Brain, et al.
Diabetologia|March 29, 2001
UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosisI M Stratton, E M Kohner, S J Aldington, et al.
Pageof 19